Chamalidou C, Fohlin H, Albertsson P, Arnesson L-G, Einbeigi Z, Holmberg E, et al. Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up. Breast. 2021;59:294–300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilson N, Ironside A, Diana A, Oikonomidou O. Lobular breast Cancer: a review. Front Oncol. 2021;10.

Du T, Zhu L, Levine KM, Tasdemir N, Lee AV, Vignali DAA et al. Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism. Sci Rep. 2018;8(1).

Oesterreich S, Nasrazadani A, Zou J, Carleton N, Onger T, Wright MD, et al. Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast Cancer. JNCI: J Natl Cancer Inst. 2022;114(11):1511–22.

Article  PubMed  PubMed Central  Google Scholar 

Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, et al. Distinct clinical and prognostic features of infiltrating Lobular Carcinoma of the breast: combined results of 15 international breast Cancer Study Group clinical trials. J Clin Oncol. 2008;26(18):3006–14.

Article  PubMed  Google Scholar 

Chumsri S, Li Z, Shachner T, Advani P, Sideras K, Moreno-Aspitia A, et al. Outcome and immune landscape of HER2-positive invasive lobular carcinoma in the North Central Cancer Treatment Group (NCCTG) N9831 (Alliance) trial. J Clin Oncol. 2021;39(15_suppl):535.

Article  Google Scholar 

Yang C, Lei C, Zhang Y, Zhang J, Ji F, Pan W, et al. Comparison of overall survival between invasive lobular breast carcinoma and invasive ductal breast carcinoma: a propensity score matching study based on SEER Database. Front Oncol. 2020;10:590643.

Article  PubMed  PubMed Central  Google Scholar 

Engstrøm MJ, Opdahl S, Vatten LJ, Haugen OA, Bofin AM. Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes. Histopathology. 2015;66(3):409–19.

Article  PubMed  Google Scholar 

Luo Y, Ma A, Huang S, Yu Y. Invasive lobular carcinoma has worse outcome compared with invasive ductal carcinoma in stage IV breast Cancer with Bone-Only Metastasis. Breast Care. 2022;17(3):296–305.

Article  PubMed  Google Scholar 

Bommareddy PK, Patel A, Hossain S, Kaufman HL. Talimogene Laherparepvec (T-VEC) and other Oncolytic viruses for the Treatment of Melanoma. Am J Clin Dermatol. 2017;18(1):1–15.

Article  PubMed  PubMed Central  Google Scholar 

Howells A, Marelli G, Lemoine NR, Wang Y. Oncolytic Viruses—Interaction of Virus and Tumor cells in the battle to Eliminate Cancer. Front Oncol. 2017;7.

Jayawardena N, Burga LN, Poirier JT, Bostina M. Virus–receptor interactions: structural insights for Oncolytic Virus Development. Oncolytic Virotherapy. 2019;8:39–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carter ME, Koch A, Lauer UM, Hartkopf AD. Clinical trials of oncolytic viruses in breast Cancer. Front Oncol. 2021;11.

Ang L, Guo L, Wang J, Huang J, Lou X, Zhao M. Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer. Cancer Lett. 2020;479:42–53.

Article  PubMed  Google Scholar 

Aldrak N, Alsaab S, Algethami A, Bhere D, Wakimoto H, Shah K, et al. Oncolytic herpes Simplex Virus-based therapies for Cancer. Cells. 2021;10(6):1541.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsumura S, Nakamori M, Tsuji T, Kato T, Nakamura M, Ojima T, et al. Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer. Oncotarget. 2021;12(4):344–54.

Article  PubMed  PubMed Central  Google Scholar 

Gonzalez-Pastor R, Goedegebuure PS, Curiel DT. Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer. Cancer Gene Ther. 2021;28(5):375–89.

Article  CAS  PubMed  Google Scholar 

Manyam M, Stephens AJ, Kennard JA, LeBlanc J, Ahmad S, Kendrick JE, et al. A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer. Gynecol Oncol. 2021;163:481–9.

Article  CAS  PubMed  Google Scholar 

Suryawanshi YR, Schulze AJ. Oncolytic viruses for malignant glioma: on the verge of success? Viruses. 2021;13(7):1294.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Todo T, Ito H, Ino Y, Ohtsu H, Ota Y, Shibahara J, et al. Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. Nat Med. 2022;28(8):1630–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Special Combination of OBP-301 and Pembrolizumab. https://classic.clinicaltrials.gov/show/NCT03172819

Phase ID. Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors. https://classic.clinicaltrials.gov/show/NCT02045602

Phase IE. Administration of Oncolytic Adenovirus ICOVIR-5 in patients with Advanced or metastatic melanoma. https://classic.clinicaltrials.gov/show/NCT01864759

Larson C, Oronsky B, Reid T. AdAPT-001, an oncolytic adenovirus armed with a TGF-β trap, overcomes in vivo resistance to PD-L1-immunotherapy. Am J Cancer Res. 2022;12(7):3141–7.

CAS  PubMed  PubMed Central  Google Scholar 

Wunder T, Schmid K, Wicklein D, Groitl P, Dobner T, Lange T, et al. Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. Cancer Gene Ther. 2013;20(1):25–32.

Article  CAS  PubMed  Google Scholar 

Hensen LCM, Hoeben RC, Bots STF. Adenovirus receptor expression in Cancer and its multifaceted role in Oncolytic Adenovirus Therapy. Int J Mol Sci. 2020;21(18):6828.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mendez N, Herrera V, Zhang L, Hedjran F, Feuer R, Blair SL, et al. Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency. Biomaterials. 2014;35(35):9554–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah JR, Dong T, Phung AT, Reid T, Larson C, Sanchez AB, et al. Development of Adenovirus containing liposomes produced by Extrusion vs. homogenization: a comparison for Scale-Up purposes. Bioengineering. 2022;9(11):620.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong T, Shah JR, Phung AT, Larson C, Sanchez AB, Aisagbonhi O, et al. A local and Abscopal Effect observed with liposomal encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy. Cancers. 2023;15(12):3157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang C-H, Dong T, Phung AT, Shah JR, Larson C, Sanchez AB, et al. Full remission of CAR-Deficient tumors by DOTAP-Folate Liposome Encapsulation of Adenovirus. ACS Biomaterials Sci Eng. 2022;8(12):5199–209.

Article  CAS  Google Scholar 

Yang M, Yang CS, Guo W, Tang J, Huang Q, Feng S, et al. A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy. Cancer Biol Ther. 2017;18(11):833–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cationic Liposomes Enhance Adenovirus. Entry via a Pathway Independent of the Fiber receptor and αv-Integrins. Hum Gene Ther. 1998;9(4):507–20.

Article  Google Scholar 

Yotnda P, Chen D-H, Chiu W, Piedra PA, Davis A, Templeton NS, et al. Bilamellar Cationic liposomes protect adenovectors from Preexisting Humoral Immune responses. Mol Ther. 2002;5(3):233–41.

Article  CAS  PubMed  Google Scholar 

Liu S-H, Smyth-Templeton N, Davis AR, Davis EA, Ballian N, Li M, et al. Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice. Surgery. 2011;149(4):484–95.

Article  PubMed  Google Scholar 

Zhang Y, Wu J, Zhang H, Wei J, Wu J. Extracellular vesicles-mimetic encapsulation improves oncolytic viro-immunotherapy in tumors with low coxsackie and adenovirus receptor. Front Bioeng Biotechnol. 2020;8.

Yang L, Wang L, Su X-Q, Wang L, Chen X-C, Li D, et al. Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirus-encoding endostatin. Cancer Gene Ther. 2010;17(1):49–57.

Article  PubMed